KRT5 and cancer: Regarding the expression of the evaluated cytokeratins, the cancers associated with a germline pathogenic variant in BRCA1 were more frequently positive for CK5/6 and CK14 than tumors associated with a germline pathogenic variant in BRCA2 (p = 0.031 and p = 0.008, respectively).